Literature DB >> 21508829

Platelet ligands and ADAMTS13 during Puumala hantavirus infection and associated thrombocytopenia.

Outi Laine1, Satu Mäkelä, Jukka Mustonen, Mika Helminen, Antti Vaheri, Riitta Lassila, Lotta Joutsi-Korhonen.   

Abstract

We aimed here to elucidate the role of adhesive platelet ligands and endothelial involvement during the acute phase of Puumala hantavirus (PUUV) infection. Nineteen hospital-treated patients with serologically confirmed diagnosis of acute PUUV infection were included. Patient charts were reviewed for clinical and basic laboratory data. Plasma levels of von Willebrand factor antigen (VWF:Ag), ristocetin cofactor (VWF:RCo), factor VIII (FVIII:C) and a disintegrin and metalloproteinase with a thrombospondin type 1 domain 13 (ADAMTS13) activities as well as fibrinogen and fibronectin were measured three times acutely and once during the recovery phase. VWF:Ag and VWF:RCo were nearly three-fold higher acutely compared with recovery (median 252 vs. 88%, and mean 267 vs. 98%, respectively; P<0.001 for both), whereas FVIII:C was only slightly elevated (median 118 vs. 88%, P=0.002) and remarkably failed to show association with VWF in the acute phase. ADAMTS13 activity and fibronectin concentration were lower in the acute compared with the recovery phase (median 56 vs. 63%, P=0.003, and median 221 vs. 330 μmol/l, P=0.001, respectively). Fibrinogen raised acutely (mean 5.0 vs. 3.3 g/l, P<0.001), negatively correlating with the platelet count (r=-0.468, P=0.043). Markedly upregulated fibrinogen and VWF together with decreased levels of ADAMTS13 activity and fibronectin were observed during acute PUUV infection. VWF and FVIII:C did not associate during the acute phase, whereas thrombocytopenia correlated negatively with fibrinogen. These findings imply several rearranged interactions between platelets and their ligands.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21508829     DOI: 10.1097/MBC.0b013e328346a420

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  18 in total

Review 1.  Uncovering the mysteries of hantavirus infections.

Authors:  Antti Vaheri; Tomas Strandin; Jussi Hepojoki; Tarja Sironen; Heikki Henttonen; Satu Mäkelä; Jukka Mustonen
Journal:  Nat Rev Microbiol       Date:  2013-08       Impact factor: 60.633

2.  Dengue Virus NS1 Exposure Affects von Willebrand Factor Profile and Platelet Adhesion Properties of Cultured Vascular Endothelial Cells.

Authors:  Nitali Tadkalkar; Sharda Prasad; Shobha Gangodkar; Kanjaksha Ghosh; Atanu Basu
Journal:  Indian J Hematol Blood Transfus       Date:  2018-12-06       Impact factor: 0.900

3.  Polymorphisms of PAI-1 and platelet GP Ia may associate with impairment of renal function and thrombocytopenia in Puumala hantavirus infection.

Authors:  Outi Laine; Lotta Joutsi-Korhonen; Satu Mäkelä; Jussi Mikkelsson; Tanja Pessi; Sari Tuomisto; Heini Huhtala; Daniel Libraty; Antti Vaheri; Pekka Karhunen; Jukka Mustonen
Journal:  Thromb Res       Date:  2011-11-30       Impact factor: 3.944

4.  Von Willebrand factor is elevated in individuals infected with Sudan virus and is associated with adverse clinical outcomes.

Authors:  Anita K McElroy; Bobbie R Erickson; Timothy D Flietstra; Pierre E Rollin; Jonathan S Towner; Stuart T Nichol; Christina F Spiropoulou
Journal:  Viral Immunol       Date:  2015-02       Impact factor: 2.257

5.  Severe thrombocytopenia in hantavirus-induced nephropathia epidemica.

Authors:  J Latus; D Kitterer; S Segerer; F Artunc; M D Alscher; N Braun
Journal:  Infection       Date:  2014-11-08       Impact factor: 3.553

Review 6.  The kidney in hantavirus infection-epidemiology, virology, pathophysiology, clinical presentation, diagnosis and management.

Authors:  Felix C Koehler; Veronica Di Cristanziano; Martin R Späth; K Johanna R Hoyer-Allo; Manuel Wanken; Roman-Ulrich Müller; Volker Burst
Journal:  Clin Kidney J       Date:  2022-01-29

7.  Plasma cell-free DNA levels are elevated in acute Puumala hantavirus infection.

Authors:  Tuula K Outinen; Taru Kuparinen; Juulia Jylhävä; Sonja Leppänen; Jukka Mustonen; Satu Mäkelä; Ilkka Pörsti; Jaana Syrjänen; Antti Vaheri; Mikko Hurme
Journal:  PLoS One       Date:  2012-02-07       Impact factor: 3.240

Review 8.  Immune response during hantavirus diseases: implications for immunotherapies and vaccine design.

Authors:  Farides Saavedra; Fabián E Díaz; Angello Retamal-Díaz; Camila Covián; Pablo A González; Alexis M Kalergis
Journal:  Immunology       Date:  2021-03-18       Impact factor: 7.215

9.  The Clinical Presentation of Puumala Hantavirus Induced Hemorrhagic Fever with Renal Syndrome Is Related to Plasma Glucose Concentration.

Authors:  Johanna Tietäväinen; Satu Mäkelä; Heini Huhtala; Ilkka H Pörsti; Tomas Strandin; Antti Vaheri; Jukka Mustonen
Journal:  Viruses       Date:  2021-06-20       Impact factor: 5.048

10.  Puumala virus infections associated with cardiovascular causes of death.

Authors:  Anne-Marie Connolly-Andersen; Kristin Ahlm; Clas Ahlm; Jonas Klingström
Journal:  Emerg Infect Dis       Date:  2013-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.